01 September 2003
New method of emergency contraception
Medard M. LechCase Rep Clin Pract Rev 2003; 4(2):134-140 :: ID: 429051
Abstract
There are nor doubts, neither major controversies concerning ethical, medical and legal consequences of termination of pregnancy. In spite of this knowledge, the number of induced abortions around the world yearly exceed 50 millions. This is the especially good reason for making the emergency contraception more popular in the society and among medical professionals. Application of postcoital contraception in women who are not using or using not reliable methods of contraception (coitus interruptus, menstrual diary, spermicides etc.) means protection against fatal complications, stress, pain and humiliation of affected woman. New method of postcoital contraception (with use of two pills containing 750 mcg of levonorgestrel) during first 72 hours after unprotected intercourse with a 12 hours interval, may decrease the risk of unintended pregnancy of 74% to 99%. A split condom, refusal of one of the partners to use contraception, and violation are the main indications for the use described method of emergency contraception. The other common indication for the use of this method, is the situation when patient simply forgets to take their usual contraceptive pill or begins the new package one or two days late. The emergency contraception with use of two levonorgestrel pills, in the interval of 12 hours, should be also more widely advised for adolescent girls to avoid adolescent pregnancies with their all consequences for the health and development of the young population. One may think, if this simply method of avoidance of unwanted pregnancies should not be distributed over-the-counter, without doctor’s prescription (there are already countries where high dose levonorgestrel-pills are legally distributed by pharmacists, simply on the base of the ‘absence of contraindications’).
Keywords: Contraception, oral contraceptives, Levonorgestrel
306
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949330
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947938
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.947163
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949194
Most Viewed Current Articles
21 Jun 2024 : Case report
101,695
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
54,424
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
37,967
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
07 Jul 2023 : Case report
25,852
DOI :10.12659/AJCR.940200
Am J Case Rep 2023; 24:e940200